Related Experiment Video
Updated: Mar 7, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Phloretin Prevents High-Fat Diet-Induced Obesity and Improves Metabolic Homeostasis
Sary Alsanea1, Mingming Gao1, Dexi Liu2
1Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, 30602, USA.
Abstract:
Reactive oxygen species generated as a by-product in metabolism play a central role in the development of obesity and obesity-related metabolic complications. The objective of the current study is to explore the possibility to block obesity and improve metabolic homeostasis via phloretin, a natural antioxidant product from apple tree leaves and Manchurian apricot. Both preventive and therapeutic activities of phloretin were assessed using a high-fat diet-induced obesity mouse model. Phloretin was injected intraperitoneally twice weekly into regular and obese mice fed a high-fat diet. The effects of phloretin treatment on body weight and composition, fat content in the liver, glucose and lipid metabolism, and insulin resistance were monitored and compared to the control animals. Phloretin treatment significantly blocks high-fat diet-induced weight gain but did not induce weight loss in obese animals. Phloretin improved glucose homeostasis and insulin sensitivity and alleviated hepatic lipid accumulation. RT-PCR analysis showed that phloretin treatment suppresses expression of macrophage markers (F4/80 and Cd68) and pro-inflammatory genes (Mcp-1 and Ccr2) and enhances adiponectin gene expression in white adipose tissue. In addition, phloretin treatment elevated the expression of fatty acid oxidation genes such as carnitine palmitoyltransferase 1a and 1b (Cpt1a and Cpt1b) and reduced expression of monocyte chemoattractant protein-1 (Mcp-1), de novo lipogenesis transcriptional factor peroxisome proliferator-activated receptor-γ 2 (Pparγ2), and its target monoacylglycerol O-acyltransferase (Mgat-1) genes. These results provide direct evidence to support a possible use of phloretin for mitigation of obesity and maintenance of metabolic homeostasis.
Insights
Phloretin, a natural antioxidant, prevents high-fat diet-induced weight gain and improves metabolic health by reducing inflammation and enhancing fat oxidation. This study suggests phloretin
Area of Science:
- Metabolic disease research
- Natural product pharmacology
- Obesity research
Background:
- Reactive oxygen species (ROS) are implicated in obesity and related metabolic disorders.
- Phloretin, a natural antioxidant from apple tree leaves and Manchurian apricot, is investigated for its potential health benefits.
- Obesity management remains a significant challenge, necessitating novel therapeutic strategies.
Purpose of the Study:
- To evaluate phloretin's efficacy in preventing and treating obesity and associated metabolic complications.
- To investigate phloretin's effects on body weight, composition, and metabolic homeostasis in a mouse model.
- To explore the molecular mechanisms underlying phloretin's action in adipose tissue and the liver.
Main Methods:
- A high-fat diet-induced obesity mouse model was used to assess phloretin's preventive and therapeutic effects.
- Phloretin was administered via intraperitoneal injection twice weekly.
- Body weight, composition, liver fat content, glucose/lipid metabolism, insulin resistance, and gene expression (RT-PCR) were analyzed.
Main Results:
- Phloretin significantly blocked high-fat diet-induced weight gain but did not cause weight loss in obese mice.
- Phloretin treatment improved glucose homeostasis, insulin sensitivity, and reduced hepatic lipid accumulation.
- Phloretin modulated gene expression in white adipose tissue, suppressing inflammatory markers and enhancing adiponectin and fatty acid oxidation genes.
Conclusions:
- Phloretin demonstrates potential for mitigating obesity and maintaining metabolic homeostasis.
- The findings support the use of phloretin as a natural agent to combat obesity-related metabolic dysfunction.
- Further research into phloretin's therapeutic applications in metabolic diseases is warranted.
More Related Videos
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Cholesterol: Significance and Regulation
Considering cholesterol and...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

